 |
市场调查报告书
商品编码
1391966
酒糟治疗市场：按药物类别、按给药途径、按类型、按配销通路、按地区Rosacea Treatment Market, By Drug Class, By Route of Administration, By Type, By Distribution Channel, By Geography |
||||||
价格
简介目录
全球酒糟治疗市场规模预计将从 2023 年的 19.1 亿美元增加到 2030 年的 29.6 亿美元，预测期内复合年增长率为 6.5%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2022年 | 2023年市场规模 | 19.1亿美元 |
| 实绩资料 | 2018-2021 | 预测期 | 2023-2030 |
| 预测期复合年增长率 | 6.50% | 2030年市场规模预测 | 29.6亿美元 |
图 1. 2023 年按地区分類的酒糟治疗全球市场占有率(%)
酒糟是一种慢性皮肤病，其特征是脸部发红、潮红和有时含有脓液的小肿块。儘管这是一种令人沮丧的情况，但有多种治疗方案可供选择。为了治疗酒糟症状并改善患者的生活质量，市场提供了多种治疗选择，包括外用和内服药物药物、雷射治疗、光疗和皮肤护理产品。酒糟的实际病因尚不清楚，但可能涉及许多因素，包括遗传、环境触发因素和一些药物。
市场动态：
在预测期内，认识和诊断的提高也可能推动全球酒糟治疗市场的成长。患者和医疗保健专业人员对酒糟的了解越来越多。酒糟盛行率的上升也可能在预测期内继续推动全球酒糟治疗市场的成长。酒糟是一种广泛存在的慢性皮肤病，影响全世界数百万人。在预测期内，创新治疗方法的创造可能为全球酒糟治疗市场创造新的机会。始终需要创造新的、更好的酒糟治疗方法。
现有治疗方法的疗效有限预计将阻碍预测期内全球酒糟治疗市场的成长。儘管酒糟治疗有多种选择，但并非所有患者都能获得积极的结果。
本研究的主要特点
- 本报告对全球酒糟治疗市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和復合年增长率。
- 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
- 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球酒糟治疗市场的主要企业。
- 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
- 全球酒糟治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 透过用于分析全球酒糟治疗市场的各种策略矩阵，将促进相关人员的决策。
目录
第一章 研究目的与假设
- 研究目标
- 假设
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 酒糟盛行率上升
- 现有治疗方法的效果有限
- 创造创新治疗方法
- 影响分析
- 主要亮点
- 监管场景
- 产品发布/核准
- PEST分析
- 管道分析
- 波特的分析
- 併购场景
第四章酒糟治疗市场－冠状病毒（COVID-19）大流行的影响
- 新型冠状病毒感染疾病（COVID-19）的流行病学
- 供需面分析
- 经济影响
第 5 章酒糟治疗市场，依药物类别，2018-2030
- 介绍
- 抗生素
- α促效剂
- 类视色素A
- 皮质类固醇
- 免疫抑制剂
- 其他药物类别
第六章酒糟治疗市场，依给药途径，2018-2030
- 介绍
- 局部的
- 口服
第 7 章酒糟治疗市场，按类型，2018-2030
- 介绍
- 酒糟
- 酒糟
- 眼部酒糟
- 酒糟
第 8 章酒糟治疗市场，依配销通路，2018-2030
- 介绍
- 医院药房
- 零售药房
- 线上药房
第9章酒糟治疗市场，依地区，2018-2030
- 介绍
- 北美洲
- 美国
- 加拿大
- 雨美国
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- 东南亚国协
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第10章竞争形势
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
第11章 章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI5954
The Global Rosacea Treatment Market size is expected to reach US$ 2.96 billion by 2030, from US$ 1.91 billion in 2023, at a CAGR of 6.5% during the forecast period.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 1.91 Bn |
| Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: | 6.50% | 2030 Value Projection: | US$ 2.96 Bn |
Figure 1. Global Rosacea Treatment Market Share (%), by Region, 2023
Rosacea is a chronic skin condition characterized by redness, flushing, and sometimes small, pus-filled bumps on the face. It can be a frustrating condition to manage but there are various treatment options available. In order to cure the symptoms of rosacea and enhance patients' quality of life, the market offers a variety of treatment choices, including topical drugs, oral medications, laser therapies, light-based treatments, and skin care products, among others. The actual etiology of rosacea is unknown, but a number of factors, including genetics, environmental triggers, and some drugs, are likely to be involved.
Market Dynamics:
Increasing recognition and diagnosis will continue to fuel the growth of the global rosacea treatment market over the forecast period. Both patients and medical professionals now have a better grasp of rosacea. Rising rosacea prevalence will also continue to fuel the growth of the global rosacea treatment market over the forecast period. A widespread chronic skin disorder that affects millions of individuals worldwide is rosacea. The creation of innovative therapies will create new opportunities for the global rosacea treatment market over the forecast period. The creation of brand-new, better treatments for rosacea is constantly needed.
Limited efficacy of available treatments is expected to hamper the growth of the global rosacea treatment market over the forecast period. Despite the fact that there are numerous rosacea treatment choices, not all patients have good outcomes.
Key features of the study:
- This report provides an in-depth analysis of the global rosacea treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global rosacea treatment market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Galderma, Allergan, Bayer, Foamix Pharmaceuticals, Mayne Pharma, Leo Pharma, Pfizer, Dermira, Nestle Skin Health, Aclaris Therapeutics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global rosacea treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rosacea treatment market
Detailed Segmentation:
- Global Rosacea Treatment Market, By Drug Class:
- Antibiotics
- Alpha agonists
- Retinoids
- Corticosteroids
- Immunosuppressants
- Other drug classes
- Global Rosacea Treatment Market, By Route of Administration:
- Topical
- Oral
- Global Rosacea Treatment Market, By Type:
- Erythematotelangiectatic rosacea
- Papulopustular rosacea
- Ocular rosacea
- Phymatous rosacea
- Global Rosacea Treatment Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail pharmacies
- Online pharmacies
- Global Rosacea Treatment Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profile:
- Galderma
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Rosacea Treatment, By Drug Class
- Market Rosacea Treatment, By Route of Administration
- Market Rosacea Treatment, By Type
- Market Rosacea Treatment, By Distribution Channel
- Market Rosacea Treatment, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising Rosacea Prevalence
- Limited efficacy of available treatments
- Creation of innovative therapies
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- Pipeline Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Rosacea Treatment Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rosacea Treatment Market, By Drug Class, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Alpha agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Immunosuppressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
- Other drug classes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
6. Rosacea Treatment Market, By Route of Administration, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
7. Rosacea Treatment Market, By Type, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Erythematotelangiectatic rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Papulopustular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Ocular rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Phymatous rosacea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
8. Rosacea Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
9. Rosacea Treatment Market, By Region, 2018-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018-2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- U.S.
- Canada
- Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth,By Country, 2018 - 2030, (US$ Bn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Galderma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergan
- Bayer
- Foamix Pharmaceuticals
- Mayne Pharma
- Leo Pharma
- Pfizer
- Dermira
- Nestle Skin Health
- Aclaris Therapeutics
- Analyst Views
11. Section
- Research Methodology
- About us
